7 results about "Araliaceae" patented technology

The present invention provides a use of a ginseng herb composition in preparing products for treating COVID-19 and / or alleviating COVID-19 symptoms, related products and preparation methods thereof, and belongs to the technical field of traditional Chinese medicine preparations. The raw materials of the ginseng herb composition include the following ingredients: Ganoderma lucidum, medicinal materials of the genus Panax in the Araliaceae family, Cordyceps sinensis, and rose; wherein the medicinal materials of the genus Panax in the Araliaceae family are one or both of ginseng and American ginseng; the Cordyceps sinensis is selected from one or both of fermented Cordyceps sinensis powder and Cordyceps sinensis. Clinical trials have shown that the ginseng herb composition provided by the present invention and the products prepared therefrom can more effectively treat COVID-19 or alleviate COVID-19 symptoms, and have good taste and storage resistance.

This invention relates to the field of pharmaceutical and food technology, specifically to a coffee composition that enhances immunity. This coffee composition can be used to prepare pharmaceuticals or foods that enhance immunity and have anti-tumor effects. The coffee composition comprises an extract from an Araliaceae plant and coffee. The Araliaceae plant is one or more of ginseng, Panax notoginseng, or American ginseng. The Araliaceae plant extract comprises 2-12 parts, and coffee comprises 20-100 parts. The coffee composition may also contain extracts of the following ingredients: Codonopsis pilosula, Astragalus membranaceus, jujube, wolfberry, ginger, and licorice, with the following amounts: Codonopsis pilosula 2-5 parts, Astragalus membranaceus 2-5 parts, jujube 2-10 parts, wolfberry 2-10 parts, ginger 2-10 parts, and licorice 2-10 parts. The coffee composition of this invention exhibits significant immune-enhancing and anti-tumor activities.

The present application relates to the technical field of medicinal plant tissue culture, in particular to a rapid virus-free cloning method and reagent combination for medicinal plant tissue culture. The method comprises the following steps: pretreatment and disinfection of explants, precise virus elimination, preparation of dynamic adaptive medium, rapid propagation, real-time high-throughput detection of virus-free, seedling raising and transplanting, etc. The reagent combination comprises a multifunctional degradable reagent kit, intelligent response type nano disinfection microcapsules, special reagents such as composite virus elimination liquid, etc. The virus elimination rate is greater than or equal to 95%, the survival rate of explants is greater than or equal to 90%, the propagation cycle is shortened by 30%, the detection time is less than or equal to 2 hours, the survival rate of transplanting is greater than or equal to 85%, and the degradation rate of reagents is greater than or equal to 90%. The present application is suitable for herbaceous, woody and liana medicinal plants of the families of Araliaceae, Eucommiaceae, Orchidaceae and Campanulaceae, etc., can realize stable virus elimination and propagation effect, significantly improve the virus-free cloning efficiency and seedling quality, and meet the green production demand.

The present invention belongs to the technical field of modernization of traditional Chinese medicine, and in particular to a composition, application and product for preventing or treating chronic atrophic gastritis. The composition for preventing or treating chronic atrophic gastritis provided by the present invention is composed of isobarbin, ginsenoside Re, naringin, ginsenoside Rc and dioscorea lignin. The composition provided by the present invention can inhibit the PI3K / AKT pathway of inflammatory cells, activate the MAPK pathway of gastric mucosal epithelial cells, inhibit the expression of inflammatory factors such as IL-6 and TNF-α and promote GAST gastrin gene expression, thereby inhibiting inflammation, promoting gastrin secretion, enhancing gastric motility and promoting gastric mucosal epithelial cell repair, and achieving the effect of preventing or treating chronic atrophic gastritis. In addition, the components of the composition of the present invention are abundant in the medicinal and edible products of the Araliaceae family and the Rutaceae family, have low toxic and side effects, and show good application prospects in the preparation of drugs for preventing or treating chronic atrophic gastritis.

The invention relates to the field of research on chemical effective components of traditional Chinese medicines, and relates to a tetracyclic triterpenoid compound which is separated and identified from an araliaceae ginseng plant Panax quinquefolius L.. According to the present invention, the compounds 1-4 are new compounds, the in vitro cell experiment results show that the compounds provide significant neuroprotection effects for human neuroblastoma cells SH-SY5Y induced by an in vitro Parkinson's disease model MPP +, the preparation method of the compounds is simple, the activity is excellent, and the new material basis is provided for the prevention and treatment of Parkinson's disease (PD).

The invention provides a pharmaceutical composition for treating or preventing gallbladder cancer, which comprises the following main components: EGCG: a catechin compound extracted from green tea, the purity of which is greater than or equal to 95%; the ginsenoside Rg3 is extracted from araliaceae plant ginseng, and the purity is greater than or equal to 98%; capsaicin is extracted from red pepper, and the purity is greater than or equal to 90%; the auxiliary components comprise L-ascorbic acid, alpha-tocopherol and curcumin, the curcumin is extracted from turmeric, and the purity of the curcumin is larger than or equal to 95%; the main components and the auxiliary components in the pharmaceutical composition are proportioned as follows: an oral preparation: 20-40 mg / kg of EGCG (epigallocatechin gallate), 10-30 mg / kg of ginsenoside Rg3, 1-5 mg / kg of capsaicin, 50-100 mg / kg of L-ascorbic acid, 20-50 mg / kg of alpha-tocopherol and 10-20 mg / kg of curcumin; the invention discloses a pharmaceutical composition for treating or preventing gallbladder cancer, which is prepared from the following raw materials: 10-20 mg / kg of EGCG, 5-15 mg / kg of ginsenoside Rg3, 0.5-2 mg / kg of capsaicin, and DSPE-PEG2000 as a carrier material, the pharmaceutical composition for treating or preventing gallbladder cancer, provided by the invention, remarkably improves the anti-tumor effect through a multi-way and multi-target action mechanism, and provides a new thought and method for treating gallbladder cancer.

The invention belongs to the technical field of traditional Chinese medicine modernization, and particularly relates to a composition for preventing or treating chronic atrophic gastritis, application and a product. The composition for preventing or treating the chronic atrophic gastritis, provided by the invention, consists of isorhoifolin, ginsenoside Re, naringin, ginsenoside Rc and diosmetin. The composition provided by the invention can inhibit an inflammatory cell PI3K / AKT pathway, activate a gastric mucosa epithelial cell MAPK pathway, inhibit expression of inflammatory factors such as IL-6 and TNF-alpha and promote GAST gastrin gene expression, so that inflammation is inhibited, gastrin secretion is promoted, gastric motility is enhanced, gastric mucosa epithelial cell repair is promoted, and the effect of preventing or treating chronic atrophic gastritis is achieved. In addition, the components of the composition disclosed by the invention are rich in araliaceae and rutaceae medicinal and edible products and small in toxic and side effects, and the composition shows a good application prospect in preparation of medicines for preventing or treating chronic atrophic gastritis.